List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 582 studies with search of:   "Genentech" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
Condition: Asthma
Intervention: Drug: Xolair (omalizumab)
2 Completed A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
Condition: Psoriasis
Intervention: Drug: Raptiva (efalizumab)
3 Recruiting A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
Condition: Small Cell Lung Cancer
Interventions: Drug: bevacizumab;   Drug: chemotherapy;   Drug: placebo
4 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
5 Active, not recruiting A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: folate;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: placebo;   Drug: rituximab
6 Completed A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
7 Terminated A Safety and Efficacy Study of Xolair in Peanut Allergy
Condition: Allergy
Intervention: Drug: Xolair (omalizumab)
8 Completed A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
Condition: Cystic Fibrosis
Intervention:
9 Recruiting A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)
Conditions: Colorectal Cancer;   Non-Small Cell Lung Cancer
Intervention:
10 Active, not recruiting A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: methylprednisolone;   Drug: rituximab
11 Active, not recruiting A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab;   Drug: placebo;   Drug: erlotinib HCl
12 Active, not recruiting A Study for Patients Previously Enrolled in Study U2971g to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: methylprednisolone;   Drug: rituximab
13 Recruiting A Study of Systemic Hedgehog Antagonist With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: GDC-0449;   Drug: placebo;   Drug: bevacizumab;   Drug: chemotherapy
14 Recruiting A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
Condition: Rheumatoid Arthritis
Interventions: Drug: infliximab;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: ocrelizumab;   Drug: sham
15 Recruiting A Study of of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: trastuzumab-MCC-DM1
16 Active, not recruiting A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: folate;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: placebo;   Drug: rituximab
17 Completed A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis
Condition: Plaque Psoriasis
Intervention: Drug: Raptiva (efalizumab)
18 Active, not recruiting A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-Induced Asthma (AERO)
Condition: Asthma
Interventions: Drug: omalizumab;   Drug: placebo
19 Active, not recruiting A Study of Apomab in Patients With Advanced Chondrosarcoma
Condition: Chondrosarcoma
Intervention: Drug: apomab
20 Enrolling by invitation An Extension Study of T-DM1 in Patients Previously Treated With TDM-1
Condition: Metastatic Breast Cancer
Intervention: Drug: trastuzumab-MCC-DM1

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services